DK157878C - Fremgangsmaade til analogifremstilling af erythromycinderivater - Google Patents

Fremgangsmaade til analogifremstilling af erythromycinderivater

Info

Publication number
DK157878C
DK157878C DK007881A DK7881A DK157878C DK 157878 C DK157878 C DK 157878C DK 007881 A DK007881 A DK 007881A DK 7881 A DK7881 A DK 7881A DK 157878 C DK157878 C DK 157878C
Authority
DK
Denmark
Prior art keywords
procedure
erythromycin derivatives
analogue preparation
analogue
preparation
Prior art date
Application number
DK007881A
Other languages
English (en)
Other versions
DK7881A (da
DK157878B (da
Inventor
Solange Gouin D Ambrieres
Andre Lutz
Jean-Claude Gasc
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9237443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK157878(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of DK7881A publication Critical patent/DK7881A/da
Publication of DK157878B publication Critical patent/DK157878B/da
Application granted granted Critical
Publication of DK157878C publication Critical patent/DK157878C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK007881A 1980-01-11 1981-01-09 Fremgangsmaade til analogifremstilling af erythromycinderivater DK157878C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8000566 1980-01-11
FR8000566A FR2473525A1 (fr) 1980-01-11 1980-01-11 Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (3)

Publication Number Publication Date
DK7881A DK7881A (da) 1981-07-12
DK157878B DK157878B (da) 1990-02-26
DK157878C true DK157878C (da) 1990-07-30

Family

ID=9237443

Family Applications (1)

Application Number Title Priority Date Filing Date
DK007881A DK157878C (da) 1980-01-11 1981-01-09 Fremgangsmaade til analogifremstilling af erythromycinderivater

Country Status (25)

Country Link
US (1) US4349545A (da)
EP (1) EP0033255B1 (da)
JP (1) JPS56100799A (da)
KR (1) KR850000964B1 (da)
AU (1) AU537247B2 (da)
BG (1) BG61369B2 (da)
CA (1) CA1162535A (da)
CY (1) CY1319A (da)
DE (1) DE3165720D1 (da)
DK (1) DK157878C (da)
ES (1) ES8200702A1 (da)
FI (1) FI69473C (da)
FR (1) FR2473525A1 (da)
GR (1) GR73103B (da)
GT (1) GT198500080A (da)
HK (1) HK586A (da)
HU (1) HU187760B (da)
IE (1) IE50680B1 (da)
IL (1) IL61808A (da)
LU (1) LU88283I2 (da)
MY (1) MY8500984A (da)
NL (1) NL930097I2 (da)
OA (1) OA06719A (da)
PT (1) PT72331B (da)
ZA (1) ZA808108B (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534588B2 (fr) * 1982-10-15 1985-09-20 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
DK149776C (da) * 1984-01-06 1987-04-21 Orion Yhtymae Oy Antibiotisk virksom erytromycinforbindelse og praeparat indeholdende forbindelsen
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシンａ誘導体
NO860901L (no) 1985-03-12 1986-09-15 Beecham Group Plc Fremgangsmaate for fremstilling av farmasoeytisk aktive erytromycinderivater.
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−ｎ−メチルエリスロマイシン誘導体
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
DE3782994T2 (de) 1986-09-18 1993-04-08 Taisho Pharmaceutical Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンａオキシム及びその塩の製造方法
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
DE69227713D1 (de) 1991-03-15 1999-01-14 Merck & Co Inc 9-Deoxo-9(Z)-hydroxyiminoerythromycin A und O-Derivate hiervon
US5985844A (en) * 1992-03-26 1999-11-16 Merck & Co., Inc. Homoerythromycin A derivatives modified at the 4"-and 8A-positions
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
ES2036472B1 (es) * 1991-10-01 1994-03-01 Prodesfarma Sa Procedimiento de obtencion de eritromicina 9-(0-((2-metoxietoxi)metil)oxima) (roxitromicina).
US5210235A (en) * 1992-08-26 1993-05-11 Merck & Co., Inc. Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
US5332807A (en) * 1993-04-14 1994-07-26 Merck & Co., Inc. Process of producing 8A- and 9A-azalide antibiotics
US5795871A (en) * 1994-04-26 1998-08-18 Nobuhiro Narita Pharmaceutical composition for treatment of non-small cell lung cancer
IT1276901B1 (it) * 1994-12-13 1997-11-03 Zambon Spa Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
US5929219A (en) 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
PT102202B (pt) * 1998-09-10 2001-04-30 Hovione Sociedade Quimica S A Processo para a purificacao de roxitromicina
IN190782B (da) * 1998-09-30 2003-08-23 Max India Ltd
EP1004591B1 (en) * 1998-11-24 2003-04-09 Max India Limited Process for preparing roxithromycin and derivatives thereof
AU783055B2 (en) 1999-12-16 2005-09-22 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin polymorphs and novel polymorph IV
PT1280535E (pt) 2000-01-11 2005-04-29 Teva Pharma Processos para a preparacao de polimorfos de claritromicina
EP1313486A1 (en) 2000-02-29 2003-05-28 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
HRP20020885B1 (en) 2002-11-11 2007-05-31 GlaxoSmithKline istra�iva�ki centar Zagreb d.o.o. SUBSTITUTED 9a-N-{N'-[4-(SULFONYL)PHENYLCARBAMOYL]}DERIVATIVES 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHROMYCIN A AND 5-O-DESOZAMINYL-9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERITHRONOLIDE A
HRP20020991A2 (en) 2002-12-12 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
EP1435359A1 (en) * 2002-12-31 2004-07-07 Alembic Limited A process for the purification of roxithromycin
CA2661538A1 (en) 2006-08-24 2008-02-28 Wockhardt Research Centre Novel macrolides and ketolides having antimicrobial activity
US20090005326A1 (en) * 2007-06-26 2009-01-01 Idexx Laboratories, Inc. Single dose roxithromycin
DK2673285T3 (da) 2010-12-09 2017-10-16 Wockhardt Ltd Ketolidforbindelser
CN103619849B (zh) 2011-03-01 2016-05-25 沃克哈特有限公司 酮内酯中间体的制备方法
CA2830861C (en) 2011-03-22 2017-01-24 Wockhardt Limited Process for preparation of ketolide compounds
CN102219816A (zh) * 2011-05-12 2011-10-19 浙江国邦药业有限公司 一种罗红霉素的纯化方法
PL222631B1 (pl) 2012-11-14 2016-08-31 Gdański Univ Medyczny Kompozycja farmaceutyczna zawierająca roksytromycynę, sposób jej wytwarzania oraz zastosowanie medyczne tej kompozycji i produkt leczniczy zawierający kompozycję
CN104163840A (zh) * 2013-08-30 2014-11-26 郑州后羿制药有限公司 一种罗红霉素的精制方法
FR3049861A1 (fr) 2016-04-07 2017-10-13 Univ Claude Bernard Lyon Nouvelles compositions antivirales pour le traitement de la grippe

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU31319B (en) * 1967-08-03 1973-04-30 Pliva Pharm & Chem Works Postupak za dobijanje acil derivata eritromicin oksima
US3869444A (en) * 1972-10-10 1975-03-04 Abbott Lab Esters of erythromycin oxime
ES434842A1 (es) * 1975-02-19 1976-12-01 Andreu Sa Dr Procedimiento para la preparacion de esteres de la oxima deeritromicina.
DE2515077A1 (de) * 1975-04-07 1976-10-28 Thomae Gmbh Dr K Neue 9-alkylidenamino-erythromycine, ihre salze und verfahren zu ihrer herstellung
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf
DE2515076A1 (de) * 1975-04-07 1976-10-28 Thomae Gmbh Dr K Neue erythromycinderivate, deren salze und verfahren zu ihrer herstellung
DE2750288A1 (de) * 1977-11-10 1979-05-17 Thomae Gmbh Dr K Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
ES498395A0 (es) 1981-11-01
AU537247B2 (en) 1984-06-14
FI69473C (fi) 1986-02-10
AU6613181A (en) 1981-07-16
EP0033255B1 (fr) 1984-08-29
DK7881A (da) 1981-07-12
FI810042L (fi) 1981-07-12
ZA808108B (en) 1982-01-27
LU88283I2 (fr) 1994-09-09
JPS6237639B2 (da) 1987-08-13
KR850000964B1 (ko) 1985-07-02
HK586A (en) 1986-01-10
MY8500984A (en) 1985-12-31
EP0033255A1 (fr) 1981-08-05
HU187760B (en) 1986-02-28
FR2473525B1 (da) 1983-04-15
NL930097I1 (nl) 1993-10-01
IL61808A (en) 1986-12-31
JPS56100799A (en) 1981-08-12
US4349545A (en) 1982-09-14
KR830005258A (ko) 1983-08-03
DE3165720D1 (en) 1984-10-04
GT198500080A (es) 1987-03-06
IE50680B1 (en) 1986-06-11
PT72331B (fr) 1982-07-23
IL61808A0 (en) 1981-01-30
FR2473525A1 (fr) 1981-07-17
GR73103B (da) 1984-02-02
CA1162535A (fr) 1984-02-21
OA06719A (fr) 1982-06-30
BG61369B2 (bg) 1997-06-30
CY1319A (en) 1986-03-28
IE810046L (en) 1981-07-11
NL930097I2 (nl) 1995-04-03
DK157878B (da) 1990-02-26
ES8200702A1 (es) 1981-11-01
FI69473B (fi) 1985-10-31
PT72331A (fr) 1981-02-01

Similar Documents

Publication Publication Date Title
DK157878C (da) Fremgangsmaade til analogifremstilling af erythromycinderivater
DK534481A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK99781A (da) Fremgangsmaade til fremstilling af carboxtyrilderivater
DK2281A (da) Fremgangsmaade til fremstilling af tiazolinderivater
DK300981A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK112582A (da) Fremgangsmaade til fremstilling af triazolonderivater
DK435181A (da) Fremgangsmaade til fremstilling af thiazol-derivater
DK66582A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK161581A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK491582A (da) Fremgangsmaade til fremstilling af morphinanderivater
DK100281A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK352082A (da) Fremgangsmaade til fremstilling af ergopeptinderivater
DK160555C (da) Fremgangsmaade til fremstilling af eburnamoninderivater
DK564781A (da) Fremgangsmaade til fremstilling af pyrazoloindazolderivater
DK116982A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK172181A (da) Fremgangsmaade til fremstilling af 9-carbamoyl-9-aminoalkylfluoren-derivater
DK554581A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK449981A (da) Fremgangsmaade til fremstilling af acylderivater
DK565281A (da) Fremgangsmaade til fremstilling af quinolon-derivater
DK448981A (da) Fremgangsmaade til fremstilling af 4-chinolinmethanderivater
DK85281A (da) Fremgangsmaade til fremstilling af phenoxyderivater
DK424781A (da) Fremgangsmaade til fremstilling af quinolonderivater
DK551481A (da) Fremgangsmaade til fremstilling af triazolderivater
DK4081A (da) Fremgangsmaade til fremstilling af acylderivater
DK375882A (da) Fremgangsmaade til fremstilling af benzisoxazolderivater